Correction: Bio-Works reports first quarter 2024
Information about the company's cash position was omitted in the original release Today, Bio-Works Technologies announced net sales for the first quarter amounted to 6.1 MSEK, a 20% decrease versus the same period in 2023.The first quarter in review · Order intake amounted to 6.2 MSEK, a 44% decrease versus the same period in 2023. · Order backlog at the end of the period amounted to 4.6 MSEK. · Operating expenses (excluding raw materials) amounted to 17.1 MSEK, in-line with the company’s operating plan estimate for the first quarter. · The company’s cash position at the